FTLF vs HIMS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 22. 3% for FitLife Brands, Inc. (FTLF). FitLife Brands, Inc. (FTLF) offers the better valuation at 10. 5x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate FitLife Brands, Inc. (FTLF) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, FitLife Brands, Inc.

(FTLF) is the cheapest at 10. 5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, FitLife Brands, Inc. is actually cheaper at 7. 0x.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to +93. 5% for FitLife Brands, Inc. (FTLF). Over 10 years, the gap is even starker: FTLF returned +175. 5% versus HIMS's +161. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), FitLife Brands, Inc.

(FTLF) is the lower-risk stock at 0. 34β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 607% more volatile than FTLF relative to the S&P 500. On balance sheet safety, FitLife Brands, Inc. (FTLF) carries a lower debt/equity ratio of 37% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 22. 3% for FitLife Brands, Inc. (FTLF). On earnings-per-share growth, the picture is similar: FitLife Brands, Inc. grew EPS 68. 1% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

FitLife Brands, Inc.

(FTLF) is the more profitable company, earning 13. 9% net margin versus 5. 5% for Hims & Hers Health, Inc. — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FTLF leads at 20. 3% versus 5. 2% for HIMS. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, FitLife Brands, Inc.

(FTLF) trades at 7. 0x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 44. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FTLF: 219. 0% to $30. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, FitLife Brands, Inc.

(FTLF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 34), +175. 5% 10Y return). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FTLF: +175. 5%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FTLF (Consumer Defensive) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.